Loading…
Reported covered position: Sr. Health Policy Advisor to Senator Ron Wyden
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Employee Business Expense Deduction Reinstatement Act of 2025
Client: INSIGHTEC, LTD. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
HR 1691 and related Medicare coverage issues
Employee Business Expense Deduction Reinstatement Act of 2025
Client: INSIGHTEC, LTD. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
HR 1691 and related Medicare coverage issues
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PRIME HEALTHCARE via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · fourth_quarter · 4T
Communication and engagement regarding expansion into the state of Illinois.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREGON DEPARTMENT OF HUMAN SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · fourth_quarter · 4T
Source: Senate LDA
| CSL BEHRING | 13 | 2014–2016 |
| ELEKTA, INC. | 12 | 2013–2015 |
| OREGON HEALTH AUTHORITY | 12 | 2013–2016 |
| THE HEALTH AND HOSPITAL CORPORATION OF MARION COUNTY | 12 | 2013–2015 |
| ADEPTUS HEALTH | 11 | 2014–2017 |
| HILL-ROM COMPANY, INC. | 10 | 2013–2015 |
| CHARLES RIVER LABORATORIES | 9 | 2021–2023 |
| JOERNS HEALTHCARE | 9 | 2019–2020 |
| CONCORDANCE HEALTHCARE SOLUTIONS | 8 | 2021–2022 |
| BIOFRONTERA INC. | 7 | 2018–2019 |
| QUEST DIAGNOSTICS INCORPORATED | 7 | 2017–2018 |
| AMERICAN HEALTHCARE, LLC | 6 | 2020 |
| APEX MANAGEMENT SOLUTIONS, LLC (ON BEHALF OF APEX HEALTH, INC.) | 6 | 2022–2023 |
| HIXME | 6 | 2016–2017 |
| Nanovibronix, Inc. | 6 | 2020–2021 |
| DALLAS NEPHROLOGY ASSOCIATES | 4 | 2022 |
| IMPACT WELLNESS NETWORK | 4 | 2025 |
| OSTEAL THERAPEUTICS, INC. | 4 | 2025 |
| AMAZING HEALTHCARE HOLDINGS, LLC | 3 | 2019 |
| ASPEN CONSULTING SERVICE, LLC ON BEHALF OF KERECIS, INC. | 3 | 2024 |
| CONTINUA HEALTH ALLIANCE | 3 | 2012 |
| CONTOURMED | 3 | 2012 |
| CUA OPCO, LLC | 3 | 2023 |
| FERRING PHARMACEUTICALS, INC. | 3 | 2014 |
| GREENVILLE HOSPITAL SYSTEM | 3 | 2012 |
| OREGON DEPARTMENT OF HUMAN SERVICES | 3 | 2025 |
| PHC HOLDINGS, LLC | 3 | 2022 |
| PRIME HEALTHCARE | 3 | 2025 |
| SOLUBLE SYSTEMS | 3 | 2013–2014 |
| VALIR HEALTH, LLC | 3 | 2023 |
| AMERICAN RENAL ASSOCIATES, INC. | 2 | 2015 |
| ANJON BIOLOGICS, INC. | 2 | 2017 |
| APEXHEALTH | 2 | 2019 |
| ELECTROMEDICAL PRODUCTS INTERNATIONAL, INC. | 2 | 2019 |
| GALESBURG COTTAGE HOSPITAL | 2 | 2022 |
| GLOBAL PLASMA SOLUTIONS, INC. | 2 | 2021 |
| SUPERIOR AIR-GROUND AMBULANCE SERVICE, INC. | 2 | 2023 |
| ASL PHARMACY HOLDING COMPANY, INC. | 1 | 2013 |
| BANK OF AMERICA, N.A. | 1 | 2020 |
| COMPANIONDX | 1 | 2015 |
| DYNAVOX TECHNOLOGIES, INC. | 1 | 2014 |
Employee Business Expense Deduction Reinstatement Act of 2025
Client: INSIGHTEC, LTD. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
HR 1691 and related Medicare coverage issues
Employee Business Expense Deduction Reinstatement Act of 2025
Client: INSIGHTEC, LTD. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
HR 1691 and related Medicare coverage issues
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: INSIGHTEC, LTD. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
HR 1691 and related Medicare coverage issues
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: INSIGHTEC, LTD. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
HR 1691 and related Medicare coverage issues
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: INSIGHTEC, LTD. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
HR 1691 and related Medicare coverage issues
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: INSIGHTEC, LTD. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
HR 1691 and related Medicare coverage issues
Protecting Access to Ground Ambulance Medical Services Act of 2023
Client: SUPERIOR AIR-GROUND AMBULANCE SERVICE, INC. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Medicare and Medicaid policies relating to ground and air ambulance services. HR1666. U.S. Department of Veterans Affairs VISN issues.
Protecting Access to Ground Ambulance Medical Services Act of 2023
Client: SUPERIOR AIR-GROUND AMBULANCE SERVICE, INC. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Medicare and Medicaid policies relating to ground and air ambulance services. HR1666. U.S. Department of Veterans Affairs VISN issues.
Protecting Access to Ground Ambulance Medical Services Act of 2023
Client: SUPERIOR AIR-GROUND AMBULANCE SERVICE, INC. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Medicare and Medicaid policies relating to ground and air ambulance services. HR1666. U.S. Department of Veterans Affairs VISN issues.
Protecting Access to Ground Ambulance Medical Services Act of 2023
Client: SUPERIOR AIR-GROUND AMBULANCE SERVICE, INC. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Medicare and Medicaid policies relating to ground and air ambulance services. HR1666. U.S. Department of Veterans Affairs VISN issues.
Mobile Workforce State Income Tax Simplification Act of 2015
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Mobile Workforce State Income Tax Simplification Act of 2015
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Mobile Workforce State Income Tax Simplification Act of 2015
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Mobile Workforce State Income Tax Simplification Act of 2015
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Early Pell Promise Act
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Early Pell Promise Act
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Early Pell Promise Act
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Early Pell Promise Act
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Preserving Access to Orphan Drugs Act of 2013
Client: CSL BEHRING · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S.1128 and HR 2315
Drug Supply Chain Security Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Pharmaceutical Quality, Security, and Accountability Act S.957
Drug Supply Chain Security Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Pharmaceutical Quality, Security, and Accountability Act S.957
Drug Supply Chain Security Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Pharmaceutical Quality, Security, and Accountability Act S.957
Drug Supply Chain Security Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Pharmaceutical Quality, Security, and Accountability Act S.957
Drug Supply Chain Security Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Pharmaceutical Quality, Security, and Accountability Act S.957
Drug Supply Chain Security Act
Client: FERRING PHARMACEUTICALS, INC. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Pharmaceutical Quality, Security, and Accountability Act S.957
Pharmaceutical Quality, Security, and Accountability Act
Client: ASL PHARMACY HOLDING COMPANY, INC. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Track compounding legislation; S. 959
Pharmaceutical Quality, Security, and Accountability Act
Client: ASL PHARMACY HOLDING COMPANY, INC. · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
Track compounding legislation; S. 959
Breast Cancer Patient Equity Act of 2011
Client: CONTOURMED · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S. 1217/HR 2233 Medicare coverage for custom breast prosthetic
Breast Cancer Patient Equity Act of 2011
Client: CONTOURMED · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S. 1217/HR 2233 // Medicare coverage for custom breast prosthetic
Breast Cancer Patient Equity Act of 2011
Client: CONTOURMED · Firm: MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
S. 1217/HR 2233 // Medicare coverage for custom breast prosthetic
Medicaid, SNAP, TANF, Older Americans Act
Medicaid, SNAP, TANF, Older Americans Act
Medicaid, SNAP, TANF, Older Americans Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · fourth_quarter · 4T
HR 1691 and related Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMPACT WELLNESS NETWORK via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · fourth_quarter · 4T
Tricare payment & addiction rehabilitation services
Tricare payment & addiction rehabilitation services
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OSTEAL THERAPEUTICS, INC. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · fourth_quarter · Q4
General federal government relations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME HEALTHCARE via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · third_quarter · Q3
Communication and engagement regarding expansion into the state of Illinois.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREGON DEPARTMENT OF HUMAN SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · third_quarter · Q3
Medicaid, SNAP, TANF, Older Americans Act
Medicaid, SNAP, TANF, Older Americans Act
Medicaid, SNAP, TANF, Older Americans Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OSTEAL THERAPEUTICS, INC. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · third_quarter · Q3
General federal government relations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMPACT WELLNESS NETWORK via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · third_quarter · Q3
Tricare payment & addiction rehabilitation services
Tricare payment & addiction rehabilitation services
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · third_quarter · Q3
HR 1691 and related Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OSTEAL THERAPEUTICS, INC. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · second_quarter · Q2
General federal government relations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OSTEAL THERAPEUTICS, INC. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · second_quarter · RR
General federal government relations
PRIME HEALTHCARE via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · third_quarter · RR
Communication and engagement regarding expansion into the state of Illinois.
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · second_quarter · Q2
HR 1691 and related Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREGON DEPARTMENT OF HUMAN SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · third_quarter · RR
Medicaid, SNAP, TANF, Older Americans Act
Medicaid, SNAP, TANF, Older Americans Act
Medicaid, SNAP, TANF, Older Americans Act
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · second_quarter · 2T
Medicaid, public health, market place/exchange issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMPACT WELLNESS NETWORK via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · second_quarter · Q2
Tricare payment & addiction rehabilitation services
Tricare payment & addiction rehabilitation services
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IMPACT WELLNESS NETWORK via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · second_quarter · RR
Tricare payment & addiction rehabilitation services
Tricare payment & addiction rehabilitation services
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · first_quarter · Q1
HR 1691 and related Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2025 · first_quarter · Q1
Medicaid, public health, market place/exchange issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · fourth_quarter · Q4
Medicaid, public health, market place/exchange issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · fourth_quarter · Q4
HR 1691 and related Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED NETWORK FOR ORGAN SHARING (UNOS) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · fourth_quarter · 4T
Organ Transplant System
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · third_quarter · Q3
HR 1691 and related Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED NETWORK FOR ORGAN SHARING (UNOS) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · third_quarter · Q3
Organ Transplant System
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · third_quarter · Q3
Medicaid, public health, market place/exchange issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED NETWORK FOR ORGAN SHARING (UNOS) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · second_quarter · Q2
Issues related to organ transplants
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · second_quarter · Q2
Medicaid, public health, market place/exchange issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · second_quarter · Q2
HR 1691 and related Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASPEN CONSULTING SERVICE, LLC ON BEHALF OF KERECIS, INC. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · second_quarter · Q2
Medicare reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED NETWORK FOR ORGAN SHARING (UNOS) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · first_quarter · Q1
Issues related to organ transplants
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · first_quarter · Q1
Medicaid, public health, market place/exchange issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · first_quarter · Q1
HR 1691 and related Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASPEN CONSULTING SERVICE, LLC ON BEHALF OF KERECIS, INC. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · first_quarter · Q1
Medicare reimbursement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASPEN CONSULTING SERVICE, LLC ON BEHALF OF KERECIS, INC. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2024 · first_quarter · RR
Medicare reimbursement
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · fourth_quarter · Q4
Health reform implementation, medicaid, public health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · fourth_quarter · Q4
Medicare Issues and TriCare Coverage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED NETWORK FOR ORGAN SHARING (UNOS) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · fourth_quarter · Q4
Issues related to organ transplants
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · third_quarter · Q3
Health reform implementation, medicaid, public health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CUA OPCO, LLC via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · third_quarter · 3T
Issues related to provider relief funds
Filing targets: Health Resources & Services Administration (HRSA)
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · third_quarter · Q3
Medicare Issues and TriCare Coverage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED NETWORK FOR ORGAN SHARING (UNOS) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · third_quarter · Q3
Issues related to organ transplants
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUPERIOR AIR-GROUND AMBULANCE SERVICE, INC. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · second_quarter · RA
Medicare and Medicaid policies relating to ground and air ambulance services. HR1666. U.S. Department of Veterans Affairs VISN issues.
Medicare and Medicaid policies relating to ground and air ambulance services. HR1666. U.S. Department of Veterans Affairs VISN issues.
CUA OPCO, LLC via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · second_quarter · Q2
Issues related to provider relief funds
Filing targets: Health Resources & Services Administration (HRSA)
UNITED NETWORK FOR ORGAN SHARING (UNOS) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · second_quarter · Q2
Issues related to organ transplants
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · second_quarter · Q2
Medicare Issues and TriCare Coverage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALIR HEALTH, LLC via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · second_quarter · Q2
PACE program operational issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · second_quarter · Q2
Health reform implementation, medicaid, public health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARLES RIVER LABORATORIES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · second_quarter · 2T
Work on the need for Limulus Amebocyte Lysate (LAL) product and synthetic products to be regulated similarly in terms of safety and effectiveness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APEX MANAGEMENT SOLUTIONS, LLC (ON BEHALF OF APEX HEALTH, INC.) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · second_quarter · Q2
Medicare Advantage
Filing targets: Medicare Payment Advisory Commission (MedPAC)
CUA OPCO, LLC via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · second_quarter · RR
Issues related to provider relief funds
SUPERIOR AIR-GROUND AMBULANCE SERVICE, INC. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · second_quarter · RR
Medicare and Medicaid policies relating to ground and air ambulance services. HR1666. U.S. Department of Veterans Affairs VISN issues.
Medicare and Medicaid policies relating to ground and air ambulance services. HR1666. U.S. Department of Veterans Affairs VISN issues.
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · first_quarter · Q1
Medicare Issues and TriCare Coverage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARLES RIVER LABORATORIES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · first_quarter · Q1
Work on the need for Limulus Amebocyte Lysate (LAL) product and synthetic products to be regulated similarly in terms of safety and effectiveness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED NETWORK FOR ORGAN SHARING (UNOS) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · first_quarter · Q1
Issues related to organ transplants
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APEX MANAGEMENT SOLUTIONS, LLC (ON BEHALF OF APEX HEALTH, INC.) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · second_quarter · RA
Medicare Advantage
VALIR HEALTH, LLC via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · first_quarter · Q1
PACE program operational issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · first_quarter · Q1
Health reform implementation, medicaid, public health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALIR HEALTH, LLC via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2023 · first_quarter · RR
PACE program operational issues
CONCORDANCE HEALTHCARE SOLUTIONS via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · fourth_quarter · Q4
Work on healthcare supply chain issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED NETWORK FOR ORGAN SHARING (UNOS) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · fourth_quarter · Q4
Issues related to organ transplants
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · fourth_quarter · Q4
Health reform implementation, medicaid, public health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · fourth_quarter · Q4
Medicare issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARLES RIVER LABORATORIES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · fourth_quarter · Q4
Work on the need for Limulus Amebocyte Lysate (LAL) product and synthetic products to be regulated similarity in terms of safety and effectiveness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APEX MANAGEMENT SOLUTIONS, LLC (ON BEHALF OF APEX HEALTH, INC.) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · fourth_quarter · Q4
Medicare Advantage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DALLAS NEPHROLOGY ASSOCIATES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · third_quarter · 3T
Clarification related to APM model
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED NETWORK FOR ORGAN SHARING (UNOS) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · third_quarter · Q3
Issues related to organ transplants
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · third_quarter · Q3
Health reform implementation, medicaid, public health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · third_quarter · Q3
Medicare issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARLES RIVER LABORATORIES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · third_quarter · Q3
Work on the need for Limulus Amebocyte Lysate (LAL) product and synthetic products to be regulated similarity in terms of safety and effectiveness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Medicare Advantage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONCORDANCE HEALTHCARE SOLUTIONS via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · third_quarter · Q3
Work on healthcare supply chain issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONCORDANCE HEALTHCARE SOLUTIONS via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · second_quarter · Q2
Work on healthcare supply chain issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED NETWORK FOR ORGAN SHARING (UNOS) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · second_quarter · Q2
Issues related to organ transplants
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · second_quarter · Q2
Health reform implementation, medicaid, public health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · second_quarter · Q2
Medicare issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DALLAS NEPHROLOGY ASSOCIATES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · second_quarter · Q2
Clarification related to APM model
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARLES RIVER LABORATORIES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · second_quarter · Q2
Work on the need for Limulus Amebocyte Lysate (LAL) product and synthetic products to be regulated similarity in terms of safety and effectiveness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
APEX MANAGEMENT SOLUTIONS, LLC (ON BEHALF OF APEX HEALTH, INC.) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · second_quarter · Q2
Medicare Advantage
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHC HOLDINGS, LLC via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · second_quarter · 2T
CMMI Demonstration Project
Filing targets: SENATE
APEX MANAGEMENT SOLUTIONS, LLC (ON BEHALF OF APEX HEALTH, INC.) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · second_quarter · RR
Medicare Advantage
UNITED NETWORK FOR ORGAN SHARING (UNOS) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · first_quarter · Q1
Issues related to organ transplants
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHC HOLDINGS, LLC via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · first_quarter · Q1
CMMI Demonstration Project
Filing targets: SENATE
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · first_quarter · Q1
Health reform implementation, medicaid, public health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · first_quarter · Q1
Medicare issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DALLAS NEPHROLOGY ASSOCIATES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · first_quarter · Q1
Clarification related to APM model
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GALESBURG COTTAGE HOSPITAL via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · first_quarter · 1T
Work with CMS related to hospital survey and medicare
Filing targets: Centers For Medicare and Medicaid Services (CMS)
CHARLES RIVER LABORATORIES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · first_quarter · Q1
Work on the need for Limulus Amebocyte Lysate (LAL) product and synthetic products to be regulated similarity in terms of safety and effectiveness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONCORDANCE HEALTHCARE SOLUTIONS via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · first_quarter · Q1
Work on healthcare supply chain issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHC HOLDINGS, LLC via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · first_quarter · RR
CMMI Demonstration Project
DALLAS NEPHROLOGY ASSOCIATES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · first_quarter · RR
Clarification related to APM model
GALESBURG COTTAGE HOSPITAL via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2022 · first_quarter · RR
Work with CMS related to hospital survey and medicare
CONCORDANCE HEALTHCARE SOLUTIONS via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2021 · fourth_quarter · Q4
Work on healthcare supply chain issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2021 · fourth_quarter · Q4
Health reform implementation, medicaid, public health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2021 · fourth_quarter · Q4
Medicare issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHARLES RIVER LABORATORIES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2021 · fourth_quarter · Q4
Work on the need for Limulus Amebocyte Lysate (LAL) product and synthetic products to be regulated similarity in terms of safety and effectiveness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED NETWORK FOR ORGAN SHARING (UNOS) via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2021 · fourth_quarter · Q4
Issues related to organ transplants
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONCORDANCE HEALTHCARE SOLUTIONS via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2021 · third_quarter · Q3
Work on healthcare supply chain issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OREGON DEPARTMENT OF CONSUMER AND BUSINESS SERVICES via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2021 · third_quarter · Q3
Health reform implementation, medicaid, public health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSIGHTEC, LTD. via MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP)
2021 · third_quarter · Q3
Medicare issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE